CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Revolo Biotherapeutics

For profitWebsite ↗

Also known as: Chief Medical Officer, Revolo Biotherapeutics | Immune Regulation | Revolo Biotherapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 26, 2023

Timeline

2010s

Jan 1, 2011
Revolo Biotherapeutics— Founded

Drugs by trial phase (2 distinct, 5 trials)

Phase 2 (1 own, 0 via acquisition)

irl201104

Phase 1 (1 own, 0 via acquisition)

pin201104

Indications

Studied for

Asthma

Recent trials (8)

NCT05921591Lead sponsorPhase 1May 26, 2023
NCT05921591Study directorPhase 1May 26, 2023
NCT05084963Study directorPhase 2Nov 30, 2021
NCT05098522Lead sponsorPhase 2Nov 30, 2021
NCT05084963Lead sponsorPhase 2Nov 30, 2021
NCT05098522Study directorPhase 2Nov 30, 2021
NCT04748536Lead sponsorPhase 1Jan 29, 2021
NCT03058458Lead sponsorPhase 1Jan 1, 2017

Details

Founded: Stevenage, GB Jan 1, 2011
Last known activity: May 26, 2023

Notes

--- Pre-folding founded info: 2011-06-01 New Orleans LA United States https://www.linkedin.com/company/revolobiotherapeutics/ ---